Beverly Vaughan
Papers
1
Total Citations
10
H-Index
1
About
Beverly Vaughan is a pioneering researcher in regenerative medicine and biomanufacturing, with a focus on the scalable production of cell-based therapies. Her key contributions center on the development of automated, closed-system platforms for manufacturing mesenchymal stromal cells (MSCs), addressing critical bottlenecks in translating cell therapies from lab to clinic. Vaughan’s most cited work, "The AUTOSTEM platform for closed manufacture of bone marrow-derived mesenchymal stromal cells using a closed, scalable and automated robotic system" (2017, 10 citations), introduces a robotic system that enables consistent, sterile, and scalable MSC production—a breakthrough for reducing variability and contamination risks in cell manufacturing. This innovation has implications for treating immune and degenerative diseases, positioning Vaughan as a leader in process automation for cell therapy. Her work bridges engineering and biology, advancing Good Manufacturing Practice (GMP) compliance and paving the way for affordable, off-the-shelf cell products. Though her citation count is modest, the foundational nature of her research underscores its growing influence in the field.
Research Focus
Key Achievements
Top Papers
- 1